Hui Yan

1.1k total citations
44 papers, 711 citations indexed

About

Hui Yan is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Hui Yan has authored 44 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 14 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Hui Yan's work include Lung Cancer Diagnosis and Treatment (8 papers), Radiomics and Machine Learning in Medical Imaging (6 papers) and Cardiovascular Syncope and Autonomic Disorders (5 papers). Hui Yan is often cited by papers focused on Lung Cancer Diagnosis and Treatment (8 papers), Radiomics and Machine Learning in Medical Imaging (6 papers) and Cardiovascular Syncope and Autonomic Disorders (5 papers). Hui Yan collaborates with scholars based in China, United States and Canada. Hui Yan's co-authors include Gang Huang, Jianjun Liu, Li Zhao, Maomei Ruan, Bei Lei, Cheng Chang, Liu Liu, Junbao Du, Lihua Wang and Shuxian An and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Hui Yan

42 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui Yan China 14 215 202 164 147 123 44 711
Esmeralda Castelblanco Spain 19 102 0.5× 314 1.6× 168 1.0× 167 1.1× 80 0.7× 70 1.1k
Gianluca Bottoni Italy 17 194 0.9× 108 0.5× 196 1.2× 109 0.7× 293 2.4× 54 806
Lina Wu China 15 77 0.4× 202 1.0× 84 0.5× 89 0.6× 134 1.1× 61 753
Jeffrey R. Jacobson United States 11 354 1.6× 335 1.7× 115 0.7× 118 0.8× 48 0.4× 12 961
Serge Milin France 20 157 0.7× 336 1.7× 216 1.3× 122 0.8× 43 0.3× 44 963
Liang Hong China 19 214 1.0× 409 2.0× 131 0.8× 268 1.8× 70 0.6× 61 979
Huaien Zheng Canada 15 196 0.9× 251 1.2× 200 1.2× 74 0.5× 378 3.1× 25 1.1k
Xinyang Hu China 11 64 0.3× 260 1.3× 105 0.6× 90 0.6× 32 0.3× 34 564
Huichuan Yu China 16 125 0.6× 272 1.3× 206 1.3× 128 0.9× 80 0.7× 61 880
Martin Hunn Australia 11 66 0.3× 159 0.8× 109 0.7× 41 0.3× 49 0.4× 27 486

Countries citing papers authored by Hui Yan

Since Specialization
Citations

This map shows the geographic impact of Hui Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Yan more than expected).

Fields of papers citing papers by Hui Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Yan. The network helps show where Hui Yan may publish in the future.

Co-authorship network of co-authors of Hui Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Yan. A scholar is included among the top collaborators of Hui Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Yan. Hui Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lei, Bei, He Zhang, Jian‐Wen Sun, et al.. (2024). The Potential of Basal F-18-FDG PET/CT in Evaluating Prognosis and Benefit From Adjuvant Chemotherapy After Tumor Resection of Stage IB(T2, ≤ 3 cm With VPI, N0, M0)NSCLC. Clinical Lung Cancer. 26(1). 18–28.e6. 1 indexed citations
3.
Yan, Hui, Qiang Zhou, Fang Yang, et al.. (2023). CCNB1IP1 prevents ubiquitination‐mediated destabilization of MYCN and potentiates tumourigenesis of MYCN‐amplificated neuroblastoma. Clinical and Translational Medicine. 13(7). e1328–e1328. 5 indexed citations
4.
Ruan, Maomei, Cheng Chang, Jian‐Wen Sun, et al.. (2023). Exploring the correlation between HER2 alterations and 18F-FDG PET/CT metabolic parameters and their prognostic value in EGFR-negative non-small-cell lung cancer patients. Journal of Cancer Research and Clinical Oncology. 149(16). 14493–14507.
5.
Sun, Xiaoyan, Tianxiang Chen, Chun Xie, et al.. (2022). Relationships between SUVmax of lung adenocarcinoma and different T stages, histological grades and pathological subtypes: a retrospective cohort study in China. BMJ Open. 12(5). e056804–e056804. 5 indexed citations
6.
Yu, Tingting, et al.. (2022). A Novel Compound Heterozygous Mutation in the DNAH11 Gene Found in Neonatal Twins With Primary Ciliary Dyskinesis. Frontiers in Genetics. 13. 814511–814511. 2 indexed citations
7.
Chang, Cheng, Maomei Ruan, Bei Lei, et al.. (2022). Development of a PET/CT molecular radiomics-clinical model to predict thoracic lymph node metastasis of invasive lung adenocarcinoma ≤ 3 cm in diameter. EJNMMI Research. 12(1). 23–23. 8 indexed citations
8.
Wu, Shu, Yuanyuan Shi, Ying Liao, et al.. (2022). Establishment and Validation of a Multivariate Predictive Scoring Model for Intravenous Immunoglobulin-Resistant Kawasaki Disease: A Study of Children From Two Centers in China. Frontiers in Cardiovascular Medicine. 9. 883067–883067. 9 indexed citations
9.
Liao, Ying, Qingyou Zhang, Hui Yan, et al.. (2022). Spectrum of underlying diseases in syncope and treatment of neurally-mediated syncope in children and adolescents over the past 30 years: A single center study. Frontiers in Cardiovascular Medicine. 9. 1017505–1017505. 5 indexed citations
10.
Chang, Cheng, Xiaoyan Sun, Gang Wang, et al.. (2021). A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts ALK Rearrangement Status in Lung Adenocarcinoma. Frontiers in Oncology. 11. 603882–603882. 49 indexed citations
11.
12.
Yan, Hui, Hui Xiao, Jiujun Zhu, Jingyang Zhang, & Zhenzhen Liu. (2020). <p>Association Between the HER2 Protein Expression Level and the Efficacy of Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer</p>. Cancer Management and Research. Volume 12. 12715–12722. 8 indexed citations
13.
Wang, Lihua, Maomei Ruan, Bei Lei, et al.. (2020). The potential of 18F-FDG PET/CT in predicting PDL1 expression status in pulmonary lesions of untreated stage IIIB-IV non-small-cell lung cancer. Lung Cancer. 150. 44–52. 8 indexed citations
14.
Chen, Yongbing, Chunyu Zhang, Selena Chen, et al.. (2019). Neutrophil-to-Lymphocyte Ratio Predicts Intravenous Immunoglobulin-Resistance in Infants Under 12-Months Old With Kawasaki Disease. Frontiers in Pediatrics. 7. 81–81. 14 indexed citations
15.
Wu, Shu, Yuan Long, Selena Chen, et al.. (2019). A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old. Frontiers in Pediatrics. 7. 514–514. 17 indexed citations
16.
Huang, Zhuo, Yu Sun, Yanjie Fan, et al.. (2018). Genetic Evaluation of 114 Chinese Short Stature Children in the Next Generation Era: a Single Center Study. Cellular Physiology and Biochemistry. 49(1). 295–305. 28 indexed citations
17.
Zhao, Xiaoping, Li Zhao, Hui Yan, et al.. (2018). Non-canonical roles of PFKFB3 in regulation of cell cycle through binding to CDK4. Oncogene. 37(13). 1685–1698. 43 indexed citations
18.
Lu, Wenxin, Hui Yan, Shu Wu, et al.. (2017). Hemocytometric Measures Predict the Efficacy of Oral Rehydration for Children with Postural Tachycardia Syndrome. The Journal of Pediatrics. 187. 220–224. 12 indexed citations
19.
Yan, Hui, Yujie Chen, Lingyong Li, et al.. (2015). Decorin alleviated chronic hydrocephalus via inhibiting TGF-β1/Smad/CTGF pathway after subarachnoid hemorrhage in rats. Brain Research. 1630. 241–253. 46 indexed citations
20.
Yan, Hui, et al.. (1996). Relationship between some humoral factors and left ventricular hypertrophy in essential hypertension.. PubMed. 109(11). 885–7. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esmeralda Castelblanco Breakdown of academic impact, for papers by Gianluca Bottoni Breakdown of academic impact, for papers by Lina Wu Breakdown of academic impact, for papers by Jeffrey R. Jacobson Breakdown of academic impact, for papers by Serge Milin Breakdown of academic impact, for papers by Liang Hong Breakdown of academic impact, for papers by Huaien Zheng Breakdown of academic impact, for papers by Xinyang Hu Breakdown of academic impact, for papers by Huichuan Yu Breakdown of academic impact, for papers by Martin Hunn
Rankless by CCL
2026